Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of mitoxantrone.

R J White, F E Durr

    Investigational New Drugs
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Mitoxantrone, a novel anthracenedione, demonstrates potent anticancer activity by inhibiting DNA and RNA synthesis and inducing chromosomal aberrations. Preclinical studies show efficacy against various tumors with reduced cardiotoxicity compared to anthracyclines.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical Characteristics and Treatment of Patients Diagnosed with Pulmonary Arterial Hypertension: A Real-World Study in the USA, Europe and Japan.

    Advances in therapy·2024
    Same author

    Tube flushing and drug administration practice in patients in the community on enteral feeding.

    Clinical nutrition ESPEN·2017
    Same author

    Comparative evaluation of the functional properties of superabsorbent dressings and their effect on exudate management.

    Journal of wound care·2016
    Same author

    Changes in intestinal fluid transport in Atlantic salmon (Salmo salar L) during parr-smolt transformation.

    Fish physiology and biochemistry·2013
    Same author

    Binding and inhibition of protease enzymes, including MMPs, by a superabsorbent dressing in vitro.

    Journal of wound care·2013
    Same author

    Wound infection, dressings and pain, is there a relationship in the chronic wound?

    International wound journal·2012

    Area of Science:

    • Pharmacology
    • Medicinal Chemistry
    • Oncology

    Background:

    • Mitoxantrone is a synthetic anthracenedione antineoplastic agent.
    • Developed through synthetic chemistry programs targeting DNA intercalation.
    • Initial lead compound showed immunomodulatory and antitumor effects.

    Purpose of the Study:

    • To evaluate the antitumor activity and mechanism of action of mitoxantrone.
    • To assess its efficacy in preclinical cancer models.
    • To compare its cardiotoxicity profile with anthracycline antibiotics.

    Main Methods:

    • Synthesis and testing of anthracenedione analogues.
    • In vitro studies on DNA/RNA binding and synthesis inhibition.
    • In vivo experiments using murine tumor models.

    Related Experiment Videos

  • Combination studies with standard chemotherapeutic agents.

    • Main Results:

    • Mitoxantrone exhibits potent cytotoxic effects on proliferating and non-proliferating cells.
    • Demonstrated significant activity against various transplantable murine leukemias and solid tumors.
    • Inhibition of cellular RNA and DNA synthesis and induction of chromosomal aberrations observed.
    • Effective even when administered days before tumor implantation.
    • Therapeutic synergy observed in combination with other anticancer agents.
    • Preclinical models suggest a lack of cumulative cardiotoxicity associated with anthracyclines.

    Conclusions:

    • Mitoxantrone is a potent antineoplastic agent with a broad spectrum of activity.
    • Its mechanism involves DNA/RNA binding and inhibition of nucleic acid synthesis.
    • Shows promise as a less cardiotoxic alternative to anthracyclines in cancer therapy.